Featured Article

Nuclera Announces Appointment of Colin Barnes and Kristine Friscino to its Executive Leadership Team

CAMBRIDGE, UK (May, 2022) – Nuclera, a biotechnology company accelerating protein expression workflows, has announced the appointment of two new ...

Read article

Want to know more about our mission to change synthetic biology?

Our mission is simple: provide high-quality genes and proteins at your benchtop.

Get in touch